Omicron Hysteria Made 8 Top Pfizer, Moderna Shareholders $10 Billion Richer –
* copied from a UK article December 12, 2021
After the Omicron variant managed to hit the headlines, the CEOs and major shareholders of the Pfizer and Moderna saw a profit of a combined $10.31 billion, as per data compiled by the UK-based Global Justice Now.
Moderna shares rose 13.61% — $273.39 to $310.61 — between Nov. 24 and Dec. 1, whilst throughout the same time period Pfizer shared flew up 7.41% — $50.91 to $54.68, reports Common Dreams.
Stéphane Bancel, CEO of Moderna, witnessed his stock rise from $6.1 billion to $6.9 billion for a net revenue of $824 million. Albert Bourla, CEO of Pfizer, recorded a gain of $339,291.
The Daily Mail reported that the four major shareholders of Moderna and Pfizer, along with the CEOs, managed to accumulate around $5.16 billion.
Pfizer’s largest shareholders are Vanguard Group ($1.72 billion), Blackrock ($1.46 billion), State Street Corp. ($1.1 billion) and Capital World Investors ($909 million).
>>> I personally think that the Omicron was the last big money grab for big pharma. A full-on steal. The numbers tell the story.